Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    1575351 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Early Reversibility of Rocuronium After Different Doses of Neostigmine
Condition: Paralysis
Intervention: Drug: neostigmine

Study has passed its completion date and status has not been verified in more than two years.